FF:10706-109H4: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{f5samples | {{f5samples | ||
| | |F5samples= | ||
| | |ancestors_in_anatomy_facet=UBERON:0000015,UBERON:0000061,UBERON:0000062,UBERON:0000077,UBERON:0000465,UBERON:0000466,UBERON:0000467,UBERON:0000468,UBERON:0000475,UBERON:0000479,UBERON:0000480,UBERON:0000481,UBERON:0000916,UBERON:0000922,UBERON:0000923,UBERON:0000925,UBERON:0000926,UBERON:0000949,UBERON:0001007,UBERON:0001041,UBERON:0001048,UBERON:0001062,UBERON:0001555,UBERON:0002050,UBERON:0002100,UBERON:0002107,UBERON:0002330,UBERON:0002365,UBERON:0002368,UBERON:0002405,UBERON:0002417,UBERON:0002423,UBERON:0002530,UBERON:0002532,UBERON:0003104,UBERON:0003894,UBERON:0004119,UBERON:0004120,UBERON:0004161,UBERON:0004185,UBERON:0004921,UBERON:0005057,UBERON:0005172,UBERON:0005173,UBERON:0005177,UBERON:0005256,UBERON:0005423,UBERON:0006235,UBERON:0006925,UBERON:0007026,UBERON:0008835,UBERON:0008836,UBERON:0009142 | ||
|ancestors_in_cell_lineage_facet=CL:0000000,CL:0000003,CL:0000004,CL:0000012,CL:0000063,CL:0000066,CL:0000255,CL:0000548 | |ancestors_in_cell_lineage_facet=CL:0000000,CL:0000003,CL:0000004,CL:0000012,CL:0000063,CL:0000066,CL:0000255,CL:0000548 | ||
|ancestors_in_disease_facet=DOID:0050687,DOID:14566,DOID:162,DOID:305,DOID:4,DOID:5662,DOID:7 | |ancestors_in_disease_facet=DOID:0050687,DOID:14566,DOID:162,DOID:305,DOID:4,DOID:5662,DOID:7 | ||
| | |comment= | ||
|created_by= | |||
|creation_date= | |||
|def= | |||
|fonse_cell_line=FF:0100224,FF:0101120 | |fonse_cell_line=FF:0100224,FF:0101120 | ||
|fonse_cell_line_closure=FF:0100224,FF:0101120 | |fonse_cell_line_closure=FF:0100224,FF:0101120 | ||
Line 66: | Line 34: | ||
|fonse_treatment= | |fonse_treatment= | ||
|fonse_treatment_closure= | |fonse_treatment_closure= | ||
|has_quality= | |has_quality= | ||
|id=FF:10706-109H4 | |||
|is_a=DOID:5662;;EFO:0002091;;FF:0000003;;FF:0000210;;FF:0103191 | |is_a=DOID:5662;;EFO:0002091;;FF:0000003;;FF:0000210;;FF:0103191 | ||
|name=pleomorphic hepatocellular carcinoma cell line:SNU-387 | |||
|namespace=FANTOM5 | |namespace=FANTOM5 | ||
|part_of= | |part_of= | ||
|profile_cagescan=,,, | |||
|profile_hcage=CNhs11933,LSID835,release010,COMPLETED | |||
|profile_rnaseq=,,, | |||
|profile_srnaseq=,,, | |||
|rna_box=109 | |||
|rna_catalog_number= | |||
|rna_concentration=0.32798 | |||
|rna_extraction_protocol=OP-RNA-extraction-totalRNA-miRNeasy_Mini-v1.0 | |||
|rna_lot_number= | |||
|rna_od260/230=1.51 | |||
|rna_od260/280=2.02 | |||
|rna_position=H4 | |||
|rna_rin= | |||
|rna_sample_type=total RNA | |||
|rna_tube_id=109H4 | |||
|rna_weight_ug=8.85546 | |||
|sample_age=41 | |||
|sample_cell_catalog=CRL-2237 | |||
|sample_cell_line=SNU-387 | |||
|sample_cell_lot= | |||
|sample_cell_type=hepatocyte | |||
|sample_collaboration=FANTOM5 OSC CORE (contact: Al Forrest) | |||
|sample_company=ATCC | |||
|sample_description= | |||
|sample_dev_stage= | |||
|sample_disease=pleomorphic hepatocellular carcinoma | |||
|sample_donor(cell lot)= | |||
|sample_ethnicity=K | |||
|sample_experimental_condition= | |||
|sample_id=10706 | |||
|sample_note= | |||
|sample_sex=female | |||
|sample_species=Human (Homo sapiens) | |||
|sample_strain= | |||
|sample_tissue=liver | |||
|top_motifs=NKX2-1,4:1.79623562941;TEF:1.34093328081;DBP:1.26883133374;FOX{D1,D2}:1.20440373626;PITX1..3:1.18491227847;EVI1:1.17388949542;NFATC1..3:1.09385737397;EN1,2:1.06979032939;BPTF:1.02316127899;SMAD1..7,9:1.01839033567;HMGA1,2:1.01260796006;T:0.981228838467;SOX2:0.979590757757;TLX1..3_NFIC{dimer}:0.872868468797;ADNP_IRX_SIX_ZHX:0.819057899266;STAT5{A,B}:0.811596382481;FOXD3:0.806320638976;SP1:0.791675077694;NKX2-3_NKX2-5:0.772444447631;NKX6-1,2:0.713194749096;FOXP1:0.686213629027;PAX4:0.657314173997;LHX3,4:0.633170405011;NFY{A,B,C}:0.617854906773;TEAD1:0.588268999763;FOXL1:0.578950800933;NFE2:0.575416203832;PPARG:0.568858755599;ALX4:0.537262434705;TLX2:0.521211299412;HIF1A:0.520201023671;E2F1..5:0.514903036051;TAL1_TCF{3,4,12}:0.501631931057;TFAP2B:0.486628139176;NR1H4:0.48407446944;FOX{F1,F2,J1}:0.483282014531;FOX{I1,J2}:0.471037823155;MYB:0.465474171578;NR3C1:0.449194528314;NFIL3:0.431297183127;SOX17:0.427159863197;RFX1:0.393577719679;HOX{A5,B5}:0.379153332616;MAZ:0.372249041906;LEF1_TCF7_TCF7L1,2:0.371158472795;BACH2:0.367277395993;TFCP2:0.366455607213;IRF7:0.351443560518;HAND1,2:0.33818891811;MYOD1:0.331861005396;GFI1:0.331790088449;HBP1_HMGB_SSRP1_UBTF:0.327405567111;NANOG{mouse}:0.317842309194;FOXA2:0.315325911036;STAT2,4,6:0.311461750364;CDC5L:0.310627334911;POU6F1:0.30940012376;FOS_FOS{B,L1}_JUN{B,D}:0.29652248193;IRF1,2:0.295916305242;SOX{8,9,10}:0.274995381919;TFDP1:0.262542975553;IKZF2:0.261185672261;AHR_ARNT_ARNT2:0.258145268221;NFE2L2:0.240045529618;CEBPA,B_DDIT3:0.234219593704;RUNX1..3:0.221044954494;ELK1,4_GABP{A,B1}:0.201809362955;UFEwm:0.195637541616;ZNF143:0.193666172174;MZF1:0.191989453351;MTF1:0.185912805169;ZNF423:0.179629037896;GATA4:0.175273309865;XCPE1{core}:0.169083175454;MYBL2:0.162637095348;ZBTB16:0.146215218533;CRX:0.142071904795;NKX3-2:0.129819595144;FOSL2:0.127444532206;GTF2I:0.119169028272;HSF1,2:0.118884814263;EGR1..3:0.117931932504;SRF:0.0991053224763;HNF1A:0.0947817453267;HIC1:0.075845771674;TFAP4:0.0723828396515;HNF4A_NR2F1,2:0.0683206213096;GLI1..3:0.0620006093373;EP300:0.0580376288654;FOXQ1:0.0512110746337;HES1:0.0510853763868;FOXN1:0.0498000690889;HLF:0.0462143476831;MTE{core}:0.0446530889877;RBPJ:0.033869184087;PBX1:0.0329756335372;PDX1:0.0295871761952;PAX6:0.0253333815824;FOXP3:0.0221266218056;ESRRA:0.0144850537935;NRF1:0.00376275987092;PAX1,9:-0.00557383263637;IKZF1:-0.00961436608114;PAX2:-0.0323541327737;MED-1{core}:-0.0598810690463;FOXO1,3,4:-0.0685875568609;NR6A1:-0.072801329284;HOX{A4,D4}:-0.0806941871018;NFIX:-0.10071188754;NKX3-1:-0.103217256086;DMAP1_NCOR{1,2}_SMARC:-0.11421259137;RXR{A,B,G}:-0.11984647814;PAX3,7:-0.137164959109;NFKB1_REL_RELA:-0.13814982656;PATZ1:-0.1458964462;JUN:-0.146101569994;SREBF1,2:-0.152880018538;PRDM1:-0.161117990773;ATF5_CREB3:-0.168723430063;ZNF384:-0.174952053998;ELF1,2,4:-0.175272608571;GCM1,2:-0.175886760827;CUX2:-0.176433745764;ATF2:-0.183619184233;RFX2..5_RFXANK_RFXAP:-0.188319703536;SPIB:-0.191834098748;POU3F1..4:-0.196699555945;PAX5:-0.19695103592;MYFfamily:-0.198086100885;STAT1,3:-0.218128348409;AR:-0.218515575744;NKX2-2,8:-0.220922274283;GATA6:-0.223796788866;PAX8:-0.254756314884;ZBTB6:-0.272720018072;GFI1B:-0.2883773021;POU5F1:-0.294264571021;OCT4_SOX2{dimer}:-0.299083331127;ZIC1..3:-0.299384488725;ZFP161:-0.30013177218;XBP1:-0.300511591521;SOX5:-0.304974454461;ATF6:-0.305908653439;GTF2A1,2:-0.309452395843;TFAP2{A,C}:-0.316903243911;TBP:-0.322512058572;ARID5B:-0.325769644242;RORA:-0.373123977898;FOXM1:-0.376721064408;VSX1,2:-0.380649635945;RXR{A,B,G}_{NR1H2,PPAR}dimers:-0.38540381452;EBF1:-0.386571978528;ETS1,2:-0.386855036629;AIRE:-0.387718375769;TBX4,5:-0.390259293392;MEF2{A,B,C,D}:-0.402819065029;HOXA9_MEIS1:-0.421605831826;NFE2L1:-0.421627445546;bHLH_family:-0.429555503061;KLF4:-0.446044720831;ZNF148:-0.447943374245;PRRX1,2:-0.457542133423;YY1:-0.459621183183;NHLH1,2:-0.460406238714;ATF4:-0.464350808277;TP53:-0.472794884497;SNAI1..3:-0.478410104079;TOPORS:-0.47868344638;REST:-0.494205682203;SPI1:-0.499380205368;RXRA_VDR{dimer}:-0.50197695667;MAFB:-0.510922500498;CDX1,2,4:-0.512091259421;BREu{core}:-0.513516008452;ZNF238:-0.525908501591;ALX1:-0.555903009813;POU2F1..3:-0.565769181786;RREB1:-0.568250209067;GZF1:-0.605479559458;CREB1:-0.606904856465;ONECUT1,2:-0.627333112616;ZEB1:-0.63325380036;NR5A1,2:-0.6678577566;TGIF1:-0.698985294134;POU1F1:-0.808136580838;HMX1:-0.854933564671;HOX{A6,A7,B6,B7}:-0.932486011408;NANOG:-1.02156223805;ESR1:-1.17240076019;LMO2:-1.27125320785;ARNT_ARNT2_BHLHB2_MAX_MYC_USF1:-1.32747351407;SPZ1:-1.38952850378 | |||
}} | }} |
Revision as of 14:13, 21 March 2012
Name: | pleomorphic hepatocellular carcinoma cell line:SNU-387 |
---|---|
Species: | Human (Homo sapiens) |
Library ID: | {{{library_id}}} |
Sample type: | {{{sample_category}}} |
Genomic View: | UCSC |
CAGEd-oPOSSUM: | link |
Additional information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sample information
RNA information
|
Download raw sequence, BAM & CTSS | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Co-expression clusters with enriched expression in this sampleRanked list of co-expression cluster expression in this sample relative to the median expression in the FANTOM5 collection is shown. Value is log10 transformed. <br>Analyst:NA <br><br>link to dataset.<br>data
Repeat families with enriched expression in this sample<b>Summary:</b>Ranked list of repeat family expression in this sample relative tothe median expression in the FANTOM5 collection is shown. Value is log10transformed.<br><b>Analyst:</b>NA<br><br>link to dataset.<br>data
no result for this sample
TFBS(DNA)motifs over-represented in proximal region of promoters active in this sample
JASPAR motifs<b>Summary:</b>Association of JASPAR motif to the promoter expression in thissample. Pearson's correlation between the number of TFBSs estimated byusing the position-weight matrix for each promoter and its expression isexpressed as Z-score by taking the ones based on random position-weightmatrix, and the tail probability of the normal distribution correspondingto the Z-score is taken as the resulting P-value. Lower P-value indicatesmore (non-random) association of the motif to promoter expression<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11933
FANTOM5 phase1 novel unique motifs<b>Summary:</b>Association of the 169 novel and unique motifs discovered in FANTOM5 phase1 in this sample. Among the de-novo motifs discovered by DMF, HOMER,ChIPMunk, and ScanAll, only novel motifs are selected after comparison with known motif sets, and their clustering based on MACRO-APE resulted in169 novel and unique motifs. Their association to the promoter expression is evaluated in the same way to the JASPAR motif above<br><b>Analyst:</b> Michiel de Hoon <br><br><br>link to dataset.<br>data
library id: CNhs11933
Novel motif | Logo | P-value |
---|---|---|
1 | 1 | 0.858 |
10 | 10 | 0.117 |
100 | 100 | 0.238 |
101 | 101 | 0.58 |
102 | 102 | 0.363 |
103 | 103 | 0.259 |
104 | 104 | 0.72 |
105 | 105 | 0.404 |
106 | 106 | 0.253 |
107 | 107 | 0.315 |
108 | 108 | 0.139 |
109 | 109 | 0.887 |
11 | 11 | 0.364 |
110 | 110 | 0.854 |
111 | 111 | 0.456 |
112 | 112 | 0.108 |
113 | 113 | 0.172 |
114 | 114 | 0.149 |
115 | 115 | 0.442 |
116 | 116 | 0.642 |
117 | 117 | 0.646 |
118 | 118 | 0.774 |
119 | 119 | 0.839 |
12 | 12 | 0.418 |
120 | 120 | 0.684 |
121 | 121 | 0.276 |
122 | 122 | 0.228 |
123 | 123 | 0.566 |
124 | 124 | 0.112 |
125 | 125 | 0.718 |
126 | 126 | 0.162 |
127 | 127 | 0.643 |
128 | 128 | 0.4 |
129 | 129 | 0.92 |
13 | 13 | 0.491 |
130 | 130 | 0.345 |
131 | 131 | 0.809 |
132 | 132 | 0.455 |
133 | 133 | 0.339 |
134 | 134 | 0.415 |
135 | 135 | 0.341 |
136 | 136 | 0.243 |
137 | 137 | 0.453 |
138 | 138 | 0.817 |
139 | 139 | 0.139 |
14 | 14 | 0.522 |
140 | 140 | 0.0657 |
141 | 141 | 0.721 |
142 | 142 | 0.51 |
143 | 143 | 0.299 |
144 | 144 | 0.848 |
145 | 145 | 0.197 |
146 | 146 | 0.536 |
147 | 147 | 0.887 |
148 | 148 | 0.195 |
149 | 149 | 0.924 |
15 | 15 | 0.0347 |
150 | 150 | 0.311 |
151 | 151 | 0.917 |
152 | 152 | 0.656 |
153 | 153 | 0.275 |
154 | 154 | 0.411 |
155 | 155 | 0.236 |
156 | 156 | 0.813 |
157 | 157 | 0.171 |
158 | 158 | 0.0831 |
159 | 159 | 0.523 |
16 | 16 | 0.812 |
160 | 160 | 0.37 |
161 | 161 | 0.182 |
162 | 162 | 0.763 |
163 | 163 | 0.175 |
164 | 164 | 0.437 |
165 | 165 | 0.179 |
166 | 166 | 0.309 |
167 | 167 | 0.531 |
168 | 168 | 0.244 |
169 | 169 | 0.572 |
17 | 17 | 0.0832 |
18 | 18 | 0.0752 |
19 | 19 | 0.318 |
2 | 2 | 0.344 |
20 | 20 | 0.287 |
21 | 21 | 0.0899 |
22 | 22 | 0.992 |
23 | 23 | 0.381 |
24 | 24 | 0.46 |
25 | 25 | 0.179 |
26 | 26 | 0.679 |
27 | 27 | 0.431 |
28 | 28 | 0.177 |
29 | 29 | 0.402 |
3 | 3 | 0.62 |
30 | 30 | 0.453 |
31 | 31 | 0.729 |
32 | 32 | 0.11 |
33 | 33 | 0.997 |
34 | 34 | 0.177 |
35 | 35 | 0.0957 |
36 | 36 | 0.439 |
37 | 37 | 0.143 |
38 | 38 | 0.271 |
39 | 39 | 0.923 |
4 | 4 | 0.467 |
40 | 40 | 0.0725 |
41 | 41 | 0.295 |
42 | 42 | 0.447 |
43 | 43 | 0.535 |
44 | 44 | 0.166 |
45 | 45 | 0.323 |
46 | 46 | 0.299 |
47 | 47 | 0.182 |
48 | 48 | 0.619 |
49 | 49 | 0.462 |
5 | 5 | 0.0291 |
50 | 50 | 0.946 |
51 | 51 | 0.234 |
52 | 52 | 0.824 |
53 | 53 | 0.475 |
54 | 54 | 0.915 |
55 | 55 | 0.0561 |
56 | 56 | 0.999 |
57 | 57 | 0.812 |
58 | 58 | 0.437 |
59 | 59 | 0.233 |
6 | 6 | 0.662 |
60 | 60 | 0.784 |
61 | 61 | 0.467 |
62 | 62 | 0.441 |
63 | 63 | 0.869 |
64 | 64 | 0.872 |
65 | 65 | 0.263 |
66 | 66 | 0.0637 |
67 | 67 | 0.506 |
68 | 68 | 0.16 |
69 | 69 | 0.197 |
7 | 7 | 0.829 |
70 | 70 | 0.0573 |
71 | 71 | 0.599 |
72 | 72 | 0.172 |
73 | 73 | 0.834 |
74 | 74 | 0.223 |
75 | 75 | 0.361 |
76 | 76 | 0.511 |
77 | 77 | 0.743 |
78 | 78 | 0.324 |
79 | 79 | 0.963 |
8 | 8 | 0.637 |
80 | 80 | 0.795 |
81 | 81 | 0.101 |
82 | 82 | 0.231 |
83 | 83 | 0.481 |
84 | 84 | 0.486 |
85 | 85 | 0.705 |
86 | 86 | 0.706 |
87 | 87 | 0.225 |
88 | 88 | 0.881 |
89 | 89 | 0.133 |
9 | 9 | 0.697 |
90 | 90 | 0.653 |
91 | 91 | 0.307 |
92 | 92 | 0.599 |
93 | 93 | 0.398 |
94 | 94 | 0.11 |
95 | 95 | 0.00204 |
96 | 96 | 0.742 |
97 | 97 | 0.203 |
98 | 98 | 0.00389 |
99 | 99 | 0.528 |
de novo motifs identified by HOMER in promoters active in this sample<b>Summary:</b>The result of HOMER in this sample is shown.<br><b>Analyst:</b>NA <br>
library id: CNhs11933
FANTOM5 (FF) ontology
Direct parent terms
is_a relathionship
DOID:5662 pleomorphic carcinoma
EFO:0002091 biological replicate
FF:0000003 cell line sample
FF:0000210 human sample
FF:0103191 SNU-387 cell sample
Ancestor terms (non development)<b>Summary:</b>Connected ontology terms with is_a, part_of or located_in relationship <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source data<br>data
CL: Cell type
0000000 (cell), 0000000 (cell)
0000003 (native cell)
0000066 (epithelial cell)
0000255 (eukaryotic cell)
0000548 (animal cell)
DOID: Disease
0050687 (cell type cancer)
14566 (disease of cellular proliferation)
162 (cancer)
305 (carcinoma)
4 (disease)
5662 (pleomorphic carcinoma)
7 (disease of anatomical entity)
UBERON: Anatomy
0000015 (anatomical boundary)
0000061 (anatomical structure)
0000062 (organ)
0000077 (mixed endoderm/mesoderm-derived structure)
0000465 (material anatomical entity)
0000466 (immaterial anatomical entity)
0000467 (anatomical system)
0000468 (multi-cellular organism)
0000475 (organism subdivision)
0000479 (tissue)
0000480 (anatomical group)
0000481 (multi-tissue structure)
0000916 (abdomen)
0000922 (embryo)
0000923 (germ layer)
0000925 (endoderm)
0000926 (mesoderm)
0000949 (endocrine system)
0001007 (digestive system)
0001041 (foregut)
0001048 (primordium)
0001062 (anatomical entity)
0001555 (digestive tract)
0002050 (embryonic structure)
0002100 (trunk)
0002107 (liver)
0002330 (exocrine system)
0002365 (exocrine gland)
0002368 (endocrine gland)
0002405 (immune system)
0002417 (abdominal segment of trunk)
0002423 (hepatobiliary system)
0002530 (gland)
0002532 (epiblast (generic))
0003104 (mesenchyme)
0003894 (liver primordium)
0004119 (endoderm-derived structure)
0004120 (mesoderm-derived structure)
0004161 (septum transversum)
0004185 (endodermal part of digestive tract)
0004921 (subdivision of digestive tract)
0005057 (immune organ)
0005172 (abdomen element)
0005173 (abdominal segment element)
0005177 (trunk region element)
0005256 (trunk mesenchyme)
0005423 (developing anatomical structure)
0006235 (foregut-midgut junction)
0006925 (digestive gland)
0007026 (primitive gut)
0008835 (hepatic diverticulum)
0008836 (liver bud)
0009142 (entire embryonic mesenchyme)
FF: FANTOM5
NA
Ancestor terms (development)<b>Summary:</b>Connected ontology terms with develops_from, derives_from or preceded_by relationship <br><b>Analyst:</b> Hideya Kawaji <br><br>link to source data<br>data
NA